- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-20-0019871

Omnicrux Life Sciences Private Limited
About Omnicrux Life Sciences Private Limited
Data last updated:
Omnicrux Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 24 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2019PTC136330. Its GSTIN is 36AADCF8908L1Z7 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Madhavi Varalwar and Rohit Dansingh Negi.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 450 Alexandria Knowledge Park Turkapally Hyderabad Ranga Red, Telangana, India – 500078.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.33 Cr, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹32.38 Lakh (net margin 13.9%) and EBITDA of ₹40.77 Lakh (EBITDA margin 17.5%).
Omnicrux Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0019871).
Company details
Recognitions & Rankings of Omnicrux Life Sciences
Contact details
Omnicrux Life Sciences Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address450 Alexandria Knowledge Park Turkapally Hyderabad Ranga Red, Telangana, India – 500078
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Omnicrux Life Sciences is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Omnicrux Life Sciences Private Limited, buy the company report.
Financials of Omnicrux Life Sciences Private Limited
FY 2025 filings availableOmnicrux Life Sciences Private Limited reported revenue of ₹2.33 Cr (down 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 28% in the latest year. EBITDA rose 449% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹40.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.5% | ||||
| Net Profit Margin | 13.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Omnicrux Life Sciences Private Limited, buy the company report.
Board of directors of Omnicrux Life Sciences Private Limited
Omnicrux Life Sciences has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhavi Varalwar | Director | 24 Oct 2019 | 7 Years 0 Months | Current |
| Rohit Dansingh Negi Also directs: Omnikam Private Limited, Omnicals Pharma Private Limited | Director | 01 Dec 2023 | 2 Years 11 Months | Current |
| Annakulam Vivekanandan | Director | 02 Sep 2022 | 4 Years 2 Months | Current |
| Anurag Bhoop Narayan Pathak | Director | 01 Dec 2023 | 2 Years 11 Months | Current |
| Anil Kashiram Fokmare Also directs: Omnikam Private Limited, Omnicals Pharma Private Limited | Additional Director | 14 Jun 2025 | 1 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Omnicrux Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Omnicrux Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Omnicrux Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCF8908L1Z7 | Telangana | Active | 01 Nov 2019 |
To see the full GST registrations and return filing status of Omnicrux Life Sciences Private Limited, buy the company report.
Recent activity
Omnicrux Life Sciences Private Limited has 13 board changes on record since 2019: 6 appointments and 7 cessations. The latest: Anil Kashiram Fokmare was appointed as Additional Director on 14 Jun 2025.
4 earlier events are in the company report.
Frequently asked questions
Omnicrux Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 24 October 2019 (7+ years old) and is registered under CIN U24232TG2019PTC136330.
Omnicrux Life Sciences has 5 current directors:
- Madhavi Varalwar - Director
- Rohit Dansingh Negi - Director
- Annakulam Vivekanandan - Director
- Anurag Bhoop Narayan Pathak - Director
- Anil Kashiram Fokmare - Additional Director
The latest financial statements of Omnicrux Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Omnicrux Life Sciences is 36AADCF8908L1Z7, registered in Telangana.
The CIN (Corporate Identification Number) of Omnicrux Life Sciences is U24232TG2019PTC136330. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Omnicrux Life Sciences was incorporated on 24 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Anil Kashiram Fokmare was appointed as Additional Director on 14 Jun 2025. Nidhi Anurag Pathak ceased to be Additional Director on 27 Sep 2024. Anurag Bhoop Narayan Pathak was appointed as Director on 01 Dec 2023. Omnicrux Life Sciences has 13 board changes on record in total.
Yes, Omnicrux Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0019871).
The registered office of Omnicrux Life Sciences is at 450 Alexandria Knowledge Park Turkapally Hyderabad Ranga Red, Telangana, India – 500078.
Omnicrux Life Sciences operates in the pharma industry, in the pharma contract r and d segment.

